Thalassa Holdings Ltd
Trading Update
Für Sie zusammengefasst
- Thalassa acquires 8 million shares in Surgical Innovations.
- Stake in Surgical Innovations rises to 10.80%.
- Company focuses on minimally invasive surgery solutions.
Thalassa Holdings Ltd (THAL) |
Thalassa Holdings Ltd
(Reuters: THAL.L, Bloomberg: THAL:LN)
(“Thalassa, “THAL” or the “Company”)
Trading Update
(Reuters: THAL.L, Bloomberg: THAL:LN)
(“Thalassa, “THAL” or the “Company”)
Trading Update
The Board of the Company wishes to announce the acquisition by the Company of 8,000,000 shares of Surgical Innovations Group plc, a UK company listed on the London Stock Exchange’s AIM, increasing the Company’s stake in Surgical Innovations Group plc to 10.80%.
Surgical Innovations Group plc (AIM: SUN), ‘specialises in the design and manufacture of creative solutions for use in minimally invasive surgery (MIS) and industrial markets. [Their] pioneering products are developed in close collaboration with international surgeons to ensure they meet patients’ needs and remain at the forefront of innovation’.
https://www.sigroupplc.com/
END
Investor Enquiries: | enquiries@thalassaholdingsltd.com |
Thalassa Holdings Ltd |
Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
ISIN: | VGG878801114 |
Category Code: | TST |
TIDM: | THAL |
LEI Code: | 2138002739WFQPLBEQ42 |
Sequence No.: | 340653 |
EQS News ID: | 1968291 |
End of Announcement | EQS News Service |
|
1 im Artikel enthaltener WertIm Artikel enthaltene Werte